The MiniMed™ 780G system is approved for people with type 1 diabetes age 7 and above.
Pumps
MiniMed™ 780G insulin pump
<p>The MiniMed™ 780G system is an automated insulin delivery system consisting of an insulin pump and integrated CGM for people living with diabetes.</p>
Features
What is Meal Detection™ technology?
The MiniMed™ 780G system uses current and past sensor glucose trends to detect a missed meal bolus*
If the system detects a meal based on the sensor glucose's rising rate of change, it can automatically deliver stronger correction doses while sensor glucose values are rising, up to every 5 minutes.
To learn more about how Meal Detection™ technology works, watch this video featuring distinguished engineer, Lou Lintereur.
Clinical summaries
Due to inherent analysis limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences.
Designed for ease of use
Improvements made with both patients and healthcare providers in mind
Guardian™ 4 sensor
No fingersticks with SmartGuard™ technology§ and less interaction required, reducing the number of alerts
Medtronic Extended™ infusion set
Only infusion set with up to 7 days of wear for fewer interruptions||
Meal Detection™ technology
Automatically adjusts and corrects blood glucose every 5 minutes†
Quality of life
94% of users are satisfied with the impact of the MiniMed™ 780G system on their glucose level control and quality of life1
Recommended settings
Safely treats to a low glucose target of 100 mg/dL without increasing hypoglycemia when using recommended settings2
Recommended settings¶ of 100 mg/dL and 2 hr AIT have shown consistent results globally.2 Real-world results** in adults showed patients achieved up to 80% Time in Range with recommended settings¶ without increasing hypoglycemia.2
Auto
basal
100 mg/dL (default)
Optional: 110 mg/dL, 120 mg/dL
Auto
correction
120 mg/dL
(default is set to on)
User-initiated
corrections
120 mg/dL
(fixed target)
Specifications
1. MiniMed™ 780G insulin pump
with advanced SmartGuard™ technology
2. Guardian™ 4 sensor and transmitter
with no fingersticks with SmartGuard™ automation§
3. Medtronic Extended™ infusion set
for up to 7 days of wear||
4. MiniMed™ Mobile app
Allows patients to view glucose levels, pump information, and insulin data on their phone or Apple Watch. View this reference chart for a list of compatible smartphones.
MiniMed™ Mobile app
For patients
- Displays pump and CGM data with customizable alerts
- Time in Range viewed on demand
CareLink™ Connect app
For care partners
- All-in-one viewing and customizable alerts of patient's pump and CGM data
Frequently asked questions
Yes, a new prescription is required for the MiniMed™ 780G system. This applies to the software upgrade as well.
Two ways to prescribe:
- Submit your prescription to Medtronic through your EMR:
MiniMed™ Distribution Corp.
NCPDP ID: 5900990
NPI number: 1831418672
18302 Talavera Ridge
San Antonio, TX 78257-2605
Phone: 877-891-6750
- Submit your prescription to Medtronic via Fax: Fax: 818-576-6641
What to include in the prescription:
In the direction section of the ePrescribe screen or on written prescriptions:
MiniMed™ 780G pump
NDC: 63000-075854
Include the following:
- SmartGuard™ Target: 100 (recommended as clinically appropriate)*, 110, and 120 mg/dL
Note: System will default to 100 mg/dL. - Active Insulin Time: 2 hours (recommended)
- SmartGuard™ Warmup/Manual Mode: Suspend before low (recommended) or Suspend on low
Extended infusion set & Reservoir
NDCs: 05244-0023-28 & 63000-0497-18
Include the following:
- Total Daily Dose
- Indicate: Change infusion set & reservoir every 7 days (recommended)
Guardian™ 4 sensor & transmitter
NDCs: 63000-0445-15 & 63000-0413-38
Indicate the following:
- Change sensor every 7 days (recommended)
If we need any additional information, we will contact your office. For additional prescribing information, download the MiniMed™ 780G system prescription guide.
Yes, the FDA has approved the MiniMed™ 780G system and Medicare has completed the coding verification process. Patient orders will follow the normal processes for shipping.
Using the system does not completely replace fingersticks but patients will likely check their blood glucose less frequently. The Guardian™ 4 sensor does not require a blood glucose fingerstick to calibrate the system or make treatment decisions with SmartGuard™ technology†. For much of the time, patients will not need to do a fingerstick. However, when using the Guardian™ 4 sensor with the MiniMed™ 780G system, safety precautions were put in place to maximize the performance of the SmartGuard™ algorithm. Because of this, there are instances when the pump will prompt a blood glucose request from the user.
* Refers to SmartGuard™ technology. Some user interaction required. Individual results may vary.
† Fingersticks required in manual mode & to enter SmartGuard™. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard™.
Yes. The MiniMed™ 780G system transmits to the patient's smartphone via wireless technology. Patients and care partners are able to see real-time sugar trends on a smartphone anytime. Available to download at no cost for most iOS and Android smartphones. View this reference chart for a list of compatible smartphones.
At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours. This is classified as IPX8 rating. See user guide for more details. The sensor and transmitter are water-resistant at 8 feet (2.4 meters) for up to 30 minutes. CGM readings may not be transmitted from the CGM to the pump while in water.
* Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating
† Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off
‡ Refers to SmartGuard™ feature. Individual results may vary
§ Fingersticks required in manual mode & to enter SmartGuard™. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard™
|| The extended wear infusion set can be worn for up to 7 days. Current infusion sets are recommended for up to 3 days of wear
¶ Recommended settings in adults: SmartGuard™ Target: 100 mg/dL, 2 hr AIT, ages <=15: Start at SmartGuard™ Target: 110mg/Dl and reduce to 100 mg/Dl if no hypos, 2 hr AIT
** Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences.
1. Medtronic data on file: MiniMed™ 780G users survey conducted in April – May 2021 in UK, Sweden, Italy, Netherlands and Belgium. N = 789 †comparison of MM670G/MM770G pivotal with MiniMed™ 780G system w/G4S CAS (Avg. 12.12 for MM670G and 7.61 for MiniMed™ 780G system in a day)
2. Arrieta A, et al. Diabetes Obes Metab. 2022;10.1111/dom.14714.